Freshness Index 2024: Legacy Drugs Dominate Revenues

 
• By Edwin Elmhirst
  
Hourglass with coins
As blockbuster drugs lose patent protection and sales decline, big pharma companies must replenish aging portfolios. (Shutterstock)

More from Scrip

More from Business